Drug Patent Expirations in March 2011 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration AZOPT Alcon brinzolamide 5,240,923*PED Mar 1, 2011 SYMLIN Amylin pramlintide acetate 6,610,824 Mar 3, 2011 NITROLINGUAL PUMPSPRAY Pohl Boskamp nitroglycerin 5,186,925 Mar 6, 2011 SYMLIN Amylin pramlintide acetate 6,610,824 Mar 8, 2011 SYMLIN Amylin […]
In this recent video from Biotech Showcase 2011. My good friend Stan Yakatan provides his perspectives on his decades spent in the biotechnology industry. Check it out; he’s got some excellent insights.
I have selected these management-themed articles from the Journal of Commercial Biotechnology, exploring the practical aspects of product innovation, R&D, patent law and marketing. The collection is divided into distinct sections: Commentary; Policy; Commercial Strategy; Valuation/Licensing; Funding; Intellectual Property; International; and Case Studies. These articles are only fully readable for a limited period of time, […]
The February 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 17, Issue 1 Editorial Applying design thinking to biotechnology PDF Yali Friedman Commentary Building biotechnology by design: An entrepreneur’s perspective PDF Arthur A Boni Building biotechnology by design: Role […]
I will be teaching Biotechnology Management (TECH 566) again this spring at the National Institutes of Health Foundation for Advanced Education in the Sciences. The focus of this course is on learning the skills necessary to succeed in the biotechnology industry. Classes are comprised of a combination of lectures based on my textbook, Building Biotechnology, […]
Drug Patent Expirations in January 2011 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration VITRAVENE PRESERVATIVE FREE Novartis fomivirsen sodium 5,276,019 Jan 4, 2011 ELIGARD Tolmar Therap leuprolide acetate 5,278,201 Jan 11, 2011 ULTIVA Bioniche Teoranta remifentanil hydrochloride 5,019,583*PED Jan 12, 2011 XELODA Hoffmann La Roche capecitabine 4,966,891 […]